These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 5067205)

  • 21. Toxicological investigations of 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370). 2. Study of teratogenic activity in rabbits and rats.
    Gaetani M; Debeus R
    Arzneimittelforschung; 1972 Jan; 22(1):Suppl 1a:223-6. PubMed ID: 5067197
    [No Abstract]   [Full Text] [Related]  

  • 22. Phenylprenazone in osteoarthritis.
    Cannella M; Curioni GB; Barabino P; Montanari C
    Curr Ther Res Clin Exp; 1973 Feb; 15(2):52-5. PubMed ID: 4632506
    [No Abstract]   [Full Text] [Related]  

  • 23. [Clinico-therapeutic experiences with a new anti-inflammatory agent: DA 2370].
    Scanni A; Ferrari P
    Minerva Med; 1973 Oct; 64(71):3718-24. PubMed ID: 4588363
    [No Abstract]   [Full Text] [Related]  

  • 24. [Further trials of anti-inflammatory agents in inflammatory gynecological diseases].
    Cazzola D
    Ann Ostet Ginecol Med Perinat; 1980; 101(6):426-42. PubMed ID: 7008678
    [No Abstract]   [Full Text] [Related]  

  • 25. [Treatment of inflammatory adnexal diseases of women with Irgapyrin].
    Silomon R
    Med Welt; 1969 Nov; 48():2649-51. PubMed ID: 5386516
    [No Abstract]   [Full Text] [Related]  

  • 26. [Current possibilities of treatment of pelvic inflammations].
    Foglia G; Azzarà A
    Minerva Ginecol; 1978 Jun; 30(6):565-70. PubMed ID: 673259
    [No Abstract]   [Full Text] [Related]  

  • 27. [Further use of Venopyronum in inflammatory pelvic diseases in women].
    Moslener CD
    Ther Ggw; 1965 Aug; 104(8):1097-102. PubMed ID: 5845749
    [No Abstract]   [Full Text] [Related]  

  • 28. Pharmacological investigations of 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedion (DA 2370). 4. Analgesic activity on bradykinin evoked pain in rats.
    Lumachi
    Arzneimittelforschung; 1972 Jan; 22(1):Suppl 1a:201-2. PubMed ID: 5067192
    [No Abstract]   [Full Text] [Related]  

  • 29. [Phenylprenazone in pediatrics. Pharmacokinetic and clinical study].
    Buffatti GA; Chierichetti S; Gamba A
    Minerva Pediatr; 1973 Sep; 25(30):1273-9. PubMed ID: 4797367
    [No Abstract]   [Full Text] [Related]  

  • 30. [A new drug with anti-inflammatory and re-epithelializing action on the female genital mucosa. Clinical study].
    Rasconà F; Cortellessa L
    Minerva Ginecol; 1976 Feb; 28(2):183-91. PubMed ID: 1256720
    [No Abstract]   [Full Text] [Related]  

  • 31. [Preliminary clinical trial of a new nonsteroid anti-inflammatory agent in gynecology].
    Camusi R; Marinucci S; Casini E
    Minerva Ginecol; 1976 May; 28(5):447-51. PubMed ID: 1018825
    [No Abstract]   [Full Text] [Related]  

  • 32. Physico-chemical and analytical studies on 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370).
    Perego R; Gallazzi A; Vanoni PC; Lucarella I
    Arzneimittelforschung; 1972 Jan; 22(1):Suppl 1a:177+. PubMed ID: 5067189
    [No Abstract]   [Full Text] [Related]  

  • 33. [Clinical results obtained in obstetrics and gynecology with the use of a new tetracycline salt with a 6-amino benzoxazine compound].
    Capra A; Coppo F; Massobrio M; Giordano G
    Minerva Ginecol; 1968 Sep; 20(18):1534-41. PubMed ID: 5754282
    [No Abstract]   [Full Text] [Related]  

  • 34. Toxicological investigations of 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370). 1. Subacute and chronic toxicity in rats and dogs.
    Gaetani M; Debeus R; Bonardi G; Coppi G
    Arzneimittelforschung; 1972 Jan; 22(1):Suppl 1a:216+. PubMed ID: 5067196
    [No Abstract]   [Full Text] [Related]  

  • 35. Biochemical investigations of 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370). 4. Effects on erythrocyte membrane lysis and on red cells aggregation.
    Coppi G; Bonardi G
    Arzneimittelforschung; 1972 Jan; 22(1):Suppl 1a:247-9. PubMed ID: 5067201
    [No Abstract]   [Full Text] [Related]  

  • 36. Pharmacological investigations of 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370). 3. General pharmacological properties.
    Bianchi C; Bonardi G
    Arzneimittelforschung; 1972 Jan; 22(1):Suppl 1a:196+. PubMed ID: 5067191
    [No Abstract]   [Full Text] [Related]  

  • 37. Biochemical investigations of 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370). 2. Action on local and systemic chemical responses in the rat with an experimental inflammatory process.
    Coppi G; Bonardi G
    Arzneimittelforschung; 1972 Jan; 22(1):Suppl 1a:237+. PubMed ID: 5067200
    [No Abstract]   [Full Text] [Related]  

  • 38. [Pancreatic proteolytic enzymes in obstetrics and gynecology].
    Marchetto G
    Minerva Ginecol; 1971 Sep; 23(18):741-5. PubMed ID: 5131182
    [No Abstract]   [Full Text] [Related]  

  • 39. [Clinical experience with the combination of sulfamethoxazole and trimethoprim in gynecology and obstetrics].
    Roosen D
    Arzneimittelforschung; 1971 May; 21(5):588-9. PubMed ID: 5109677
    [No Abstract]   [Full Text] [Related]  

  • 40. Pharmacological investigations of 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370). 2. Ulcerogenic effects in rats and dogs.
    Marazzi-Uberti E; Bianchi C; Gaetani M; Pozzi L
    Arzneimittelforschung; 1972 Jan; 22(1):Suppl 1a:191-6. PubMed ID: 5067472
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.